Collection 專利 [0/18] 期刊論文 [157/157] 會議論文/會議摘要 [23/37] Siblings 伍素瑩 [52/65] 其他 [58/60] 夏克山 [76/98] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [18/18] 張竣評 [21/26] 徐祖安 [170/215] 李秀珠 [75/105] 李靜琪 [23/24] 林書玉 [19/20] 洪明秀 [31/40] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [35/39] 童俊維 [23/23] 紀雅惠 [21/25] 翁紹華 [22/24] 莊宏 [1/1] 葉修華 [24/25] 葉燈光 [133/152] 蔣維棠 [41/66] 謝興邦 [171/231] 趙宇生(2002-2013) [120/212] 郭靜娟 [49/55] 鄒倫 [28/29] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:19(8.96%) 含全文筆數:180(84.91%) 文件下載次數統計 下載大於0次:180(100.00%) 下載大於100次:176(97.78%) 檔案下載總次數:97521(1.82%) 最後更新時間: 2024-12-01 03:19 Top Upload Loading... Top Download Loading... Recent Submissions DBPR116, a prodrug of BPRMU191, in ... Discovery of a mu-opioid receptor m... Discovery of a long half-life AURKA... Postfermented tea extract potently ... Natural fucoidans inhibit coronavir... Development of furanopyrimidine-bas... The synergistic inhibition of coron... Omicron-specific mRNA vaccine induc... BPR0C261, an analogous of microtubu... Protective effect of CXCR4 antagoni...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 101-125 of 212. (9 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 > >> View [10|25|50] records per page

Date	Title	Relation
2013-10	Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats	Journal of Controlled Release. 2013 Oct;172(2):513-522.
2013-10	Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT	Biomaterials. 2013 Oct;34(32):7994-8001.
2013-07	Andrographis paniculata extract and andrographolide modulate the hepatic drug metabolism system and plasma tolbutamide concentrations in rats	Evidence-Based Complementary and Alternative Medicine. 2013 Jul;2013:Article number 982689.
2013-06-28	Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor	Journal of Medicinal Chemistry. 2013 Jun 28;56(13):5247-5260.
2013-06-05	Anticancer oral formulation	EP2310363B1/2013-06-05
2013-06	Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry. 2013 Jun;21(11):2856-2867.
2013-06	Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence	Journal of Microbiology. 2013 Jun;51(3):345-351.
2013-05	H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline in senescent human fetal mesenchymal stem cells	Antioxidants and Redox Signaling. 2013 May;18(15):1895-1905.
2013-05	Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	Proceedings of the National Academy of Sciences of the United States of America. 2013 May;110(19):E1779-E1787.
2013-04-07	BPR000K, a novel Aurora kinase inhibitor	Abstracts of Papers - American Chemical Society. 2013 Apr 7;245:Article number 300-MEDI.
2013-04-07	Development drug candidate targeting EGFR kinase: DBPR112	Abstracts of Papers - American Chemical Society. 2013 Apr 7;245:Article number 299-MEDI.
2013-04	Design and synthesis of Aurora kinase inhibitors as anticancer agents	Abstracts of Papers - American Chemical Society. 2013 Apr;245:Article number 301-MEDI.
2013-02-11	抗癌口服藥學組成物	I384984/2013-02-11
2013-01-23	In vivo imaging of brain infarct with the novel fluorescent probe psvue 794 in a rat middle cerebral artery occlusion-reperfusion model	Molecular Imaging. 2013 Jan 23;12(1):8-16.
2013-01	Effects of pH on molecular mechanisms of chitosan–integrin interactions and resulting tight-junction disruptions	Biomaterials. 2013 Jan;34(3):784-793.
2012-11	BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia	European Journal of Cancer. 2012 Nov;48(Suppl. 6):53-54.
2012-09	Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan	Biomaterials. 2012 Sep;33(26):6254-6263.
2012-09	Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors	European Journal of Medicinal Chemistry. 2012 Sep;55:32-38.
2012-09	Putative tumor metastasis-associated genes in human gastric cancer	International Journal of Oncology. 2012 Sep;41(3):1068-1084.
2012-09	HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy	Clinical Cancer Research. 2012 Sep;18(17):4691-4701.
2012-06-07	3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry Letters. 2012 Jun 7;22(14):4654-4659.
2012-06	Involvement of transcriptional regulator Ndt80 in stress responses of Candida albicans	Mycoses. 2012 Jun;55(Suppl. S4):131-132.
2012-04	Securin enhances the anti-cancer effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in human colorectal cancer cells	PLoS ONE. 2012 Apr;7(4):Article number e36006.
2012-03	R432 is a key residue for the multiple functions of Ndt80p in Candida albicans	Cellular and Molecular Life Sciences. 2012 Mar;69(6):1011-1023.
2012-02	Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents	Investigational New Drugs. 2012 Feb;30(1):164-175.

Showing items 101-125 of 212. (9 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 > >> View [10|25|50] records per page